Old Web
English
Sign In
Acemap
>
authorDetail
>
Joel Chen
Joel Chen
Cleveland Clinic
Chemistry
Cancer research
Antibody-drug conjugate
T cell
Regimen
3
Papers
1
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A CD6-Targeted Antibody-Drug Conjugate As a Potential Therapy for T Cell-Mediated Disorders
2021
Blood
Linjun Zhang
Liping Luo
Joel Chen
Rupesh Singh
William M. Baldwin
David A. Fox
Daniel J. Lindner
Feng Lin
Show All
Source
Cite
Save
Citations (0)
CD6-Targeted Antibody–Drug Conjugate As a Potential Therapeutic Agent for T Cell Lymphomas
2021
Blood
Neetha Parameswaran
Liping Luo
Lingjun Zhang
Joel Chen
David A. Fox
Eric D. Hsi
Deepa Jagadeesh
Feng Lin
Show All
Source
Cite
Save
Citations (0)
A Pilot Clinical Trial of Oral Tetrahydrouridine/Decitabine for Non-Cytotoxic Epigenetic Therapy of Chemo-resistant Lymphoid Malignancies
2020
Seminars in Hematology
Brian T. Hill
Deepa Jagadeesh
Brad Pohlman
Robert M. Dean
Neetha Parameswaran
Joel Chen
Tomas Radivoyevitch
Ashley Morrison
Sherry Fada
Meredith Dever
Shelley Beth Robinson
Daniel J. Lindner
Mitchell R. Smith
Yogen Saunthararajah
Show All
Source
Cite
Save
Citations (1)
1